Kynurenine levels in pregnant women with kidney disease
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at a substance called kynurenine in the blood of pregnant women who have chronic kidney disease (CKD) compared to those who don't. It aims to understand how kidney function affects this substance during pregnancy, which may help improve care for women with kidney issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and less than 14 weeks along (before the start of the second trimester).
- You either have chronic kidney disease (CKD) stage 2, 3, or 4 (moderate to severe decrease in kidney function) diagnosed before pregnancy, or you have normal kidney function.
- You are not pregnant with more than one baby (e.g., twins or triplets).
- You have not had a kidney transplant.
- You are able to give informed consent and are covered by a social security system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to predict and diagnose chronic kidney disease (long-term kidney damage) in people who had pre-eclampsia during pregnancy, including related serious conditions. It may help identify kidney problems earlier so care can start sooner.
This study tests a new approach to prevent long-term heart and kidney problems in people who had preeclampsia, HELLP syndrome, or kidney disease during pregnancy. It aims to see if early follow-up care can improve future health.
This study looks at how well your blood vessels work during pregnancy to help predict high blood pressure disorders. If you join, you will have extra monitoring and blood tests.
This study looks at “uremic toxins,” which are waste products that build up when kidney function is reduced, and how they relate to health outcomes in people with chronic kidney disease. The results may help doctors better understand what to monitor and target to improve care.
This trial is checking if certain proteins in your blood (called placental growth factor and nucleosomes) during early pregnancy can help predict problems like preeclampsia or preterm birth. If you join, you'll give a blood sample during your regular NIPT test, and researchers will follow your pregnancy to see how it goes.
This study tracks the health of women with kidney problems before, during, and after pregnancy to learn how to better care for them. It is for women who have had kidney disease, high blood pressure, certain pregnancy complications, or a kidney transplant.
Hear when a new Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.